Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolotherapy vs Lidocaine in Myofascial Pain Syndrome
NCT05239091Completed
- Sponsor
- Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
- Start
- Aug 2022
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Randomised trial of dextrose in myofascial pain syndrome (MPS) (2 arms), sponsored by Istanbul Physical Medicine and Rehabilitation Training and Research Hospital. Primary endpoint: Pressure pain threshold at 8 weeks. Started Aug 2022; status: completed.
02
Drugs
dextrose
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT05239091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05239091.